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Avascular necrosis of the femoral head (ANFH) is a debilitating disease that commonly leads to destruction of the
hip joint in adults. The etiology of ANFH is unknown, but previous studies have indicated that heritable throm-
bophilia (increased tendency to form thrombi) and hypoﬁbrinolysis (reduced ability to lyse thrombi), alcohol intake,
and steroid use are risk factors for ANFH. We recently identiﬁed two families with ANFH showing autosomal
dominant inheritance. By applying linkage analysis to a four-generation pedigree, we excluded linkage between the
family and three genes related to thrombophilia and hypoﬁbrinolysis: protein C, protein S, and plasminogen activator
inhibitor. Furthermore, by a genomewide scan, a signiﬁcant two-point LOD score of 3.45 (recombination fraction
[ ] ) was obtained between the family with ANFH and marker D12S85 on chromosome 12. High-resolutionv p 0
mapping was conducted in a second family with ANFH and replicated the linkage to D12S368 (pedigree I: LOD
score 2.47, ; pedigree II: LOD score 2.81, ). When an age-dependent–penetrance model wasvp 0.05 vp 0.10
applied, the combined multipoint LOD score was 6.43 between D12S1663 and D12S85. Thus, we mapped the
candidate gene for autosomal dominant ANFH to a 15-cM region between D12S1663 and D12S1632 on chro-
mosome 12q13.
Avascular necrosis of the femoral head (ANFH) is a de-
bilitating disease that usually leads to destruction of the
hip joint in the 3rd to 5th decade of life (average age
36 years) (Mont and Hungerford 1995). As a clinical
entity, the disease is characterized by progressive pain in
the groin, mechanical failure of the subcondral bone,
and degeneration of the hip joint. ANFH represents a
speciﬁc form of the broader disease category of osteo-
necrosis. Although ANFH shares with osteonecrosis the
same histopathological features and possibly the same
etiology, the affected tissue is restricted to the hip joints
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in ANFH (see the work of Assouline-Dayan et al. [2002]
for a review of osteonecrosis). The disease prevalence is
unknown, but it has been estimated that 10,000–20,000
new cases are diagnosed in the United States each year
(Mankin 1992; Mont and Hungerford 1995). Nearly
half of the patients eventually require hip replacement
before 40 years of age.
It has been suggested that a common pathogenesis
pathway of ANFH involves the interruption of blood
circulation to the anterior-superior-lateral part of the
femoral head, leading to ischemic insult and bone col-
lapse (Atsumi and Kuroki 1992). The disease is aggra-
vated by mechanical disruption (e.g., hip fracture [Bach-
iller et al. 2002]), external pressure on or damage to a
vessel wall (e.g., vasculitis [Wang et al. 1988], radiation
therapy [Massin and Duparc 1995], and systemic lupus
erythematosus [Abu-Shakra et al. 2003]), arterial throm-
bosis or embolism (e.g., sickle-cell disease [Milner et al.
1991], corticosteroid use [Fisher 1978], and alcohol abuse
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[Wang et al. 2003]), and venous or blood outﬂow occlu-
sion (e.g., infection [Benjamin and Khan 1994]). In ad-
dition, other pathophysiological mechanisms and etiolog-
ical factors are postulated to be associated with ANFH.
Legg-Calve-Perthes disease (LCP [MIM 150600]) is char-
acterized by loss of circulation to the femoral head, re-
sulting in avascular necrosis in a growing child. Clinical
pictures of the disease vary, depending on the phase of
disease progression through ischemia, revascularization,
fracture and collapse, and repair and remodeling of the
bone. The disease occurs more frequently in boys, and
most patients tend to be shorter than their peers. Both
familial and isolated cases of LCP have been reported.
Although a major proportion of individuals with
ANFH have underlying risk factors and are classiﬁed as
having secondary ANFH, 15%–30% of patients show-
ing no apparent risk factors are classiﬁed as having pri-
mary or idiopathic ANFH (Assouline-Dayan et al.
2002). It has been proposed that many cases of ANFH
previously considered idiopathic actually are associated
with heritable thrombophilia (an increased tendency for
intravascular thrombosis) or hypoﬁbrinolysis (a reduced
ability to lyse thrombi) (Glueck et al. 1997, 2001; Jones
et al. 2003). Deﬁciency of antithrombotic protein C or
protein S, resulting in thrombophilia, has been reported
to be associated with osteonecrosis of the hip (Glueck
et al. 1997) and of the jaws (Glueck et al. 1996b) in
adults and with LCP in children (Glueck et al. 1994b).
On the other hand, hypoﬁbrinolysis, mediated by high
levels of plasminogen activator inhibitor (PAI), has been
cited as a major cause of idiopathic osteonecrosis
(Glueck et al. 1994a). Familial protein C and protein S
deﬁciencies and high levels of PAI are transmitted as
autosomal dominant traits (Glueck et al. 1993, 1994c,
1996a; Pierre-Jacques et al. 1997). The three genes have
been mapped on chromosome 2q13-q14 (protein C
gene) (Patracchini et al. 1989), chromosome 3q11.1-
q11.2 (protein S gene) (Watkins et al. 1988), and chro-
mosome 7q21.3-q22 (PAI gene) (Klinger et al. 1987).
Although most cases of idiopathic ANFH are spo-
radic, we recently identiﬁed two multiplex families with
ANFH that showed an autosomal dominant mode of
inheritance. Both families were from Taiwan. Affected
individuals were identiﬁed by clinical and radiological
examination. The radiographic stage of osteonecrosis of
the femoral head was graded according to the Ficat clas-
siﬁcation system (Ficat 1985). Initially, clinical and ge-
netic analyses of familial ANFH were focused on ped-
igree I. Of 75 subjects in the family, 5 males and 11
females were affected with idiopathic ANFH, including
2 twin sisters (ﬁg. 1A). In this pedigree, the mode of
inheritance was apparently autosomal dominant. Of the
12 patients whose clinical data and DNA were available
for this study, the average age at onset was 26 years
(range 15–48 years). Index patients and affected relatives
from the family presented with symptoms of pain in the
groin, and physical examination revealed that they had
average height and normal appearance in the muscu-
loskeletal system; there was no sign of chondrodys-
plasia in the patients. The twins showed no evidence
of systemic lupus erythematosus, sickle-cell disease, or
Gaucher disease. Furthermore, except for individual II-
9, the patients were not alcohol users. With the use of
the Ficat index, seven patients were graded as stage IV
and ﬁve as stage II. Subsequently, another family affected
with ANFH also was identiﬁed, and the two pedigrees
were not related to each other. As shown in ﬁgure 1B,
the second family with ANFH (designated “pedigree II”)
included 77 members in four generations. Among them,
16 (8 males and 8 females) were affected with ANFH,
with an age at onset of 12–37 years.
Three genes associated with thrombophilia and hy-
poﬁbrinolysis were investigated by linkage analysis to
identify the pathoetiologic association of heritable co-
agulation disorders with idiopathic ANFH in pedigree
I. Markers D2S410, D2S347, D2S1328, D2S368, and
D2S1334, spanning 19.9 cM, were selected for the pro-
tein C gene region. Markers D3S4529, D3S1271, and
D3S2459 covered a 6.6-cM distance for the protein S
gene. The PAI gene, residing on chromosome 7q21.3-
q22, was investigated by use of the markers D7S657,
D7S821, D7S515, and D7S1799, spanning 9.1 cM.
Two-point LOD scores were calculated for markers
near the protein C, protein S, and PAI genes, at a variety
of recombination fractions. LOD scores !2.0 were ob-
served at small recombination fractions ( ) forv  0.01
all the markers and were still negative, even at higher
recombination fractions ( ), for most markersvp 0.40
(data not shown). Furthermore, multipoint linkage re-
sults, yielded by the LINKMAP program (Lathrop et al.
1985), also showed negative LOD scores ranging from
1.21 to 21.99 for the protein C gene, 5.65 to
14.81 for the protein S gene, and 2.26 to 11.14
for the PAI gene (data not shown). By use of the criterion
of a LOD score !2, the results from the two-point and
multipoint linkage analyses provided evidence for the
exclusion of these genes as candidates for idiopathic
ANFH in this family.
We then conducted a genomewide scan for linkage
analysis in pedigree I. A signiﬁcant two-point LOD score
of 3.45 was found for the marker D12S85, and nearby
markers also showed positive LOD scores (data not
shown). Furthermore, multipoint linkage analysis re-
vealed signiﬁcant LOD scores (LOD 13) in an interval
of 33 cM spanning the markers D12S345 and D12S326
(data not shown). A peak multipoint LOD score of 4.11
was obtained between the markers D12S83 andD12S326
on chromosome 12q13. No other suggestive or signiﬁcant
LOD scores were observed for markers on the other 21
autosomes.
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Figure 1 Pedigree structure of the two families with idiopathic ANFH. Individuals whose DNA was available for linkage analysis are
indicated by an asterisk (*).
On the basis of the genomewide scan, the chromosome
12q13 region was ﬁne mapped with 29 additional mi-
crosatellite markers in pedigree I. Furthermore, we con-
ducted a replication study on pedigree II with 39 chro-
mosome 12 markers. Linkage analysis was performed
under two genetic models. Model 1 was a dominant ge-
netic model with a disease-gene frequency of 0.0001 and
a constant penetrance of 0.99 for both homozygous and
heterozygous individuals. Model 2 was an age-depen-
dent–penetrance dominant model with a disease-gene
frequency of 0.0001 and various age-dependent pene-
trances. The penetrance values were speciﬁed as 0, 0.20,
0.80, 0.99, respectively, for the following four age
groups ( ): years, years,ap age a  10 10 ! a  20
years, and years. Allele frequency for20 ! a  30 a 1 30
each marker was calculated from 24 unrelated individ-
uals, including founders and married-in individuals in
the pedigrees.
Table 1 summarizes the two-point LOD scores under
model 1 conditions. We recalculated two-point LOD
scores on the basis of the combined allele frequency of
the two families, and several markers revealed signiﬁcant
LOD scores (LOD 13) for pedigree I. In the second fam-
ily with ANFH (pedigree II), a maximum two-point
LOD score of 2.81 ( ) was found for the markervp 0.10
D12S368, which was located in the same region of sig-
niﬁcant linkage as in pedigree I. When we combined the
results of these two families, these two pedigrees gen-
erated a maximum two-point LOD score of 5.22 for the
marker D12S368 ( ).vp 0.10
By use of the same data set, we conducted multipoint
linkage analysis with the chromosome 12 markers. With
the two pedigrees combined, a maximum multipoint
LOD score of 2.54 was obtained for the interval of
D12S368–D12S803 under constant penetrance (model
1) (ﬁg. 2). Considering the age at onset for individuals
with this disease, we then performed multipoint link-
age analysis under the conditions of age-dependent pe-
netrance (model 2). With this model, a plateau of mul-
tipoint LOD scores was observed between markers
D12S1663 and D12S1632. A peak LOD score of 6.43
occurred between markers D12S1663 andD12S85. Tak-
ing together the results from the two-point and multi-
point linkage analyses, we deﬁned the interval between












Peak LOD v Peak LOD v Peak LOD v
D12S336b 19.68 .24 .30 .27 .40 .16 .40
D12S310b 36.06 .10 .30 .09 .40 .02 .40
D12S1617b 44.03 1.52 .05 .00 .40 .77 .30
D12S345b,c 53.09 .13 .30 NA … NA …
D12S1692 53.28 .80 .20 .44 .20 1.24 .20
D12S1668 55.29 2.36 .00 .14 .30 1.77 .10
D12S1653 56.38 .57 .30 1.53 .20 2.05 .20
D12S1301d 56.25 1.37 .10 .09 .30 1.20 .20
D12S1663 56.38 2.09 .00 .13 .20 1.53 .10
D12S85b 61.34 2.97 .05 1.01 .20 3.42 .20
D12S1701 62.54 3.00 .05 1.50 .20 4.20 .10
D12S2196 63.89 1.19 .10 .21 .40 .19 .30
D12S339 64.43 1.81 .10 1.05 .20 2.81 .20
D12S1635 64.96 2.35 .10 1.32 .20 3.36 .20
D12S1677 65.49 1.40 .20 .45 .20 1.85 .20
D12S368b 66.03 2.47 .05 2.81 .10 5.22 .10
D12S803 67.63 1.40 .00 1.16 .20 2.02 .20
D12S398 68.16 .00 .10 1.12 .20 1.12 .20
D12S1618 68.16 2.57 .10 .08 .30 1.89 .20
D12S1586 69.23 2.28 .10 1.48 .20 3.44 .10
D12S1724 69.82 .59 .20 1.33 .20 1.92 .20
D12S1707 69.82 .00 .20 2.62 .00 2.62 .00
D12S1632 71.61 1.86 .00 .17 .30 1.04 .20
D12S1644d 72.20 .88 .10 .77 .20 1.41 .20
D12S90 71.61 3.28 .05 .01 .40 2.95 .10
D12S305 74.58 1.21 .10 1.20 .20 2.27 .20
D12S1700d 75.76 .01 .40 .05 .40 .05 .40
D12S1056 75.17 1.29 .10 .02 .40 .85 .20
D12S1072 75.17 1.79 .10 .19 .30 1.48 .20
D12S83b,c 75.17 3.46 .05 NA … NA …
D12S298d 74.58 4.45 .00 .09 .40 2.01 .20
D12S329d 74.58 .60 .10 .21 .40 .10 .40
D12S1585d 74.76 2.72 .05 .10 .40 1.42 .20
D12S75 76.36 2.23 .05 .00 .30 1.24 .20
D12S313 79.93 1.00 .00 .16 .40 .12 .30
D12S1680 80.52 3.69 .05 .39 .40 .94 .20
D12S326b 86.40 1.61 .00 .13 .40 .33 .30
D12S346b 104.65 .05 .40 .21 .40 .26 .40
D12S324b 147.17 .27 .40 .05 .40 .23 .40
D12S1659b 155.94 .05 .40 .10 .40 .15 .40
D12S1723b 164.63 .05 .40 .13 .40 .07 .40
a Marker position on the Marshﬁeld genetic map (Marshﬁeld Center for Medical
Genetics Web site).
b Markers used for whole-genome scan.
c Markers not analyzed in pedigree II.
d Marker ordered according to the NCBI physical map.
In this study, we report two Taiwanese families with
idiopathic ANFH that showed an autosomal dominant
mode of inheritance. To our knowledge, this is the ﬁrst
study in the literature of multiple pedigrees with idio-
pathic ANFH. Although genetic factors, such as heri-
table coagulation disorders, hemoglobinopathies, and
lipid-storage diseases (Jones 1997), have been proposed
to be associated with osteonecrosis, only one case in
which an MZ twin developed an idiopathic ANFH has
been described (Nobillot et al. 1994). In fact, nearly all
cases of ANFH are sporadic. The availability of these
rare pedigrees provides an opportunity to investigate the
genetic basis for the development of idiopathic ANFH.
Furthermore, the identiﬁcation of two autosomal dom-
inant families with ANFH from Taiwan—but so far no-
where else—suggests that genetic heterogeneity in
ANFH might exist in different populations.
Step-by-step linkage analysis was conducted in the
Figure 2 Multipoint linkage analysis of chromosome 12 markers of the pedigrees with ANFH. A, Multipoint analysis was applied to the
two pedigrees with ANFH under the age-dependent model (solid line) and under the constant-penetrance model (dashed line). B, Multipoint
analysis was applied to the two pedigrees with ANFH under the constant-penetrance model, with all family members (dashed line) and with
affected individuals only (solid line). The candidate-gene region for ANFH, between D12S1663 and D12S1632, is indicated.
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families with ANFH, to map the chromosomal position
of the disease gene. A simulation study showed a prob-
ability of 79% to detect a LOD score 13 in pedigree I.
Even with this level of power, substantially negative
LOD scores were observed for the majority of ﬂanking
markers for the protein C, protein S, and PAI genes. This
indicates that the exclusion of linkage between these
three genes and ANFH is likely genuine. Indeed, a ge-
nomewide scan using medium-density STRmarkers sub-
sequently revealed a signiﬁcant LOD score of 3.45
( ) at D12S85 by two-point analysis in one of thevp 0
families (pedigree I). On this basis, high-resolutionmap-
ping was conducted for the candidate region on chro-
mosome 12, and the two-point and multipoint analyses
provided evidence that, in the two pedigrees, genetic
markers between D12S1663 and D121632 are linked to
the disease phenotype.
We observed that, in the families with ANFH, affected
individuals typically developed symptoms after age 15
years. Thus, age at onset could critically affect the results
of linkage analysis. We took into consideration that the
two pedigrees with ANFH include subjects who were
!10 years old; therefore, the LOD score was calculated
under two different conditions. As shown in ﬁgure 2A,
the LOD score increased signiﬁcantly on the assumption
that the penetrance of familial ANFH is dependent on
age. The effect is particularly prominent for the genetic
interval that shows signiﬁcant linkage. In contrast, the
enhancement of the LOD score calculated under the age-
dependent–penetrance condition is less striking for other
chromosomal regions outside the candidate region for
ANFH. Although, in some regions, LOD scores became
elevated under the age-dependent model, the LOD scores
were still below zero.
Considering the possibility that some asymptomatic
individuals in the pedigrees with ANFH might bear the
mutant allele and that the inclusion of ANFH carriers
in calculating the LOD score might obscure the linkage,
we conducted a multipoint analysis with the affected
individuals only. As shown in ﬁgure 2B, higher multi-
point LOD scores were obtained for nearly all the chro-
mosome 12 markers, but signiﬁcant linkage was ob-
served only in the interval between D12S1663 and
D12S1632. Thus, we conclude that age-dependent link-
age reﬂects a true association of the chromosome 12
region with autosomal dominant ANFH.
With the successful mapping of the ANFH locus to
chromosome 12q13, we next considered what genes in
the region could be candidate genes. Avascular necrosis
has been reported to be associated with a variety of
conditions. In trauma, there is a clear association be-
tween avascular necrosis and the disruption of the vessels
supplying the femoral head. For nontraumatic avascular
necrosis, on the other hand, many theories have been
proposed to explain the pathogenesis. These include vas-
cular occlusion, altered fat metabolism and fat emboli,
intravascular coagulation, the healing process, elevated
intracortical pressure, inhibition of angiogenesis, intra-
medullary hemorrhage, mechanical stress, and primary
bone cell death (Assouline-Dayan et al. 2002). In the
candidate region for ANFH identiﬁed by genetic map-
ping, there are 248 annotated genes and 150 known
genes between D12S1663 and D12S1632 (National
Center for Biotechnology Information [NCBI] build 34,
version 2). Among them, two closely linked genes,
COL2A1 (MIM 120140) and VDR (MIM 601769), de-
serve scrutiny. The COL2A1 gene encodes the a1 chain
of type II collagen. Mutations of the COL2A1 gene are
associated with a wide spectrum of disorders that are
attributed to anomalous expression of the gene in car-
tilage or in the vitreous humor of the eye (Ahmad et al.
1991; Bonaventure et al. 1995). To our knowledge, there
has been no previous report of a COL2A1 mutation
causing ANFH. The VDR gene encodes the vitamin D3
receptor that binds 1,25(OH)2D3 and mediates its tran-
scription regulation function through interaction with
nuclear targets. Mutations of the VDR gene have been
reported to cause vitamin D–resistant rickets (Hughes
et al. 1988). It is of interest to note that the association
of VDR gene polymorphisms and bone density has been
a subject of intensive study and debate (Hustmyer et al.
1994; Morrison et al. 1994). Furthermore, the VDR
gene and the COL2A1 gene appear to be in linkage
disequilibrium (Pedeutour et al. 1994). Given the phys-
iological relevance of the genes, they should be consid-
ered as possible candidates for ANFH.
In conclusion, our linkage results indicated that a 15-
cM region between D12S1663 and D12S1632 might
harbor a gene for ANFH. Currently, gene-based mu-
tation detection is under way to identify an ANFH dis-
ease gene from the region. We envision that, by isolating
the disease gene, it will be possible to further our un-
derstanding of the molecular mechanism of ANFHpath-
ogenesis, eventually leading to better management of
patients and/or a novel therapeutic regimen for individ-
uals with this degenerative disease.
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